Close

Puma Biotech (PBYI) to Modify Neratinib MAA Based on Feedback from CHMP's SAG

January 11, 2018 4:13 PM EST Send to a Friend
Puma Biotech (NASDAQ: PBYI) disclosed in an SEC filing:Puma Biotechnology, Inc. (the “Company”) announced that it met today with the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login